EverHint - Masimo Corporation (MASI) Stock Analysis
Analysis Date: 2026-02-17
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: NASDAQ
Executive Summary
Masimo Corporation is currently trading at $174.95 (🟢 +34.42% today) with a market capitalization of $9.40B.
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Price & Valuation
Current Price: $174.95 (at 12:27 PM ET)
Current Volume: $9.9M (avg 752K)
Day Range: $174.37 - $175.25
52-Week Range: $125.94 - $194.88
P/E Ratio: N/A
Market Context
Healthcare Sector: 0.20649%
Major Indices:
- S&P 500: $6831.47 (🔴 -0.07%)
- NASDAQ Composite: $22506.94 (🔴 -0.18%)
- Dow Jones Industrial Average: $49501.12 (🟢 +0.00%)
Peer Comparison
Peer comparison (11 companies):
- MASI - Masimo Corporation ($174.95, +34.4%) ← Current
- BAX - Baxter International Inc. ($20.43, +3.2%)
- HSIC - Henry Schein, Inc. ($77.69, -0.6%)
- ATR - AptarGroup, Inc. ($143.36, +0.5%)
- ABVX - Abivax S.A. ($124.56, -0.3%)
- RGEN - Repligen Corporation ($135.12, -1.0%)
- BIO - Bio-Rad Laboratories, Inc. ($262.94, +2.5%)
- MOH - Molina Healthcare, Inc. ($134.70, -0.5%)
- RYTM - Rhythm Pharmaceuticals, Inc. ($101.39, +3.4%)
- AVTR - Avantor, Inc. ($9.11, -1.0%)
- STVN - Stevanato Group S.p.A. ($15.79, -1.4%)
Financial Performance
Latest Quarter (2025-09-27):
- Revenue: $371.50M
- Net Income: $-100.40M
- EPS: $-1.86
- Revenue Growth (QoQ): +0.2%
Dividend Analysis
Dividend Status: ⚠️ Formerly dividend-paying (discontinued)
Last Dividend:
- Amount: $1.00 per share
- Ex-Dividend Date: 2012-11-23 (13.2 years ago)
- Payment Date: 2012-12-11
Note: This company has not paid dividends in over 13 years. The dividend program appears to have been discontinued.
Payment History: 3 historical dividend payments tracked
Earnings Calendar
Next Earnings Report: 2026-02-26 (After Market Close)
- EPS Estimate: $1.43
- Revenue Estimate: $0.41B
Most Recent Report: 2025-11-04
- EPS: $1.32 (Est: $1.19) ✓ Beat
- Revenue: $0.37B
Historical Data: 86 earnings events tracked
Analyst Outlook
Analyst Price Target Consensus:
- Target: $187.50 (+7.2% upside)
- Range: $180.00 - $200.00
- Median: $185.00
Next Quarter Estimates (2027-12-27):
- Revenue: $463.26M
- EPS: $1.85
Analyst Consensus
Overall Rating: Buy
Rating Distribution (197 total ratings):
- 🟢 Buy/Outperform: 132 (67.0%)
- ⚪ Hold/Neutral: 52 (26.4%)
- 🔴 Sell/Underperform: 7 (3.6%)
Recent Analyst Actions:
- BTIG (2025-12-04): Maintained Buy
- BTIG (2025-11-24): Maintained Buy
- Wells Fargo (2025-11-05): Maintained Overweight
- BTIG (2025-11-05): Maintained Buy
- BTIG (2025-09-11): Maintained Buy
Consensus based on 197 analyst ratings from major financial institutions
Trading Signals
Our technical analysis identified 3 trading signal(s) in the last 60 days:
- 2026-02-05: Ema10 Ema30 - EMA10_x_EMA30_Sell @ $135.33
- 2026-02-05: Ema10 Sma50 - EMA10_x_SMA50_Sell @ $135.33
- 2026-02-02: Sma20 Sma50 - SMA20_x_SMA50_Buy @ $138.42
Insider Activity
Recent Transactions (Last 10):
- Buys: 3
- Sells: 7
Notable Transactions:
- 2026-02-12: Szyman Catherine M. - Sell (Option Exercise, 11,141 shares)
- 2026-02-12: Szyman Catherine M. - Buy (Option Exercise, 11,141 shares @ $132.96)
- 2026-02-12: Szyman Catherine M. - Sell (Tax Withholding, 4,568 shares)
Congressional Trading Activity
Tracking recent stock transactions by U.S. Congress members
House of Representatives: 9 transactions tracked
Recent Activity:
- 🔴 Kevin Hern (OK01): Sale on 2025-09-26 @ $141.40, Amount: $15,001 - $50,000
- ⚪ Kevin Hern (OK01): Sale (Full) on 2022-12-19, Amount: $50,001 - $100,000
- 🔴 Ro Khanna (CA17): Sale on 2022-07-19, Amount: $1,001 - $15,000
- 🟢 Ro Khanna (CA17): Purchase on 2022-05-23, Amount: $1,001 - $15,000
- 🔴 Ro Khanna (CA17): Sale on 2022-04-11, Amount: $1,001 - $15,000
U.S. Senate: 5 transactions tracked
Recent Activity:
- ⚪ Tommy Tuberville: Sale (Full) (Joint) on 2022-10-05, Amount: $1,001 - $15,000
- ⚪ Tommy Tuberville: Sale (Full) (Joint) on 2022-10-05, Amount: $1,001 - $15,000
- 🟢 Tommy Tuberville: Purchase (Joint) on 2022-03-30, Amount: $1,001 - $15,000
- 🟢 Tommy Tuberville: Purchase (Joint) on 2022-03-30, Amount: $1,001 - $15,000
- ⚪ Thom Tillis: Sale (Full) (Joint) on 2015-02-13, Amount: $1,001 - $15,000
Congressional trading data sourced from official disclosure filings
News Sentiment Analysis
AI Analysis (based on 30 recent articles):
News sentiment for Masimo Corporation (MASI) is overwhelmingly positive due to Danaher's definitive $9.9 billion all-cash acquisition at $180 per share, driving shares up over 34%. While a few law firms are probing the deal's fairness for shareholders, the market reaction and acquisition buzz dominate. Earlier reports highlight solid financials and growth potential amid hold ratings from analysts.
Key Themes:
- Danaher Acquisition
- Stock Price Surge
- Shareholder Fairness Probes
Sentiment: Positive (92% confidence)
Recent News
5 most recent articles covering MASI:
- Shares of Masimo, Danaher Moving on Acquisition Buzz (schaeffersresearch.com, 2026-02-17) — Read more
- MASI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Masimo Corporation to Danaher Corporation (globenewswire.com, 2026-02-17) — Read more
- Danaher to acquire Masimo in $9.9B all-cash deal (proactiveinvestors.com, 2026-02-17) — Read more
- MASI Stock Alert: Halper Sadeh LLC is Investigating Whether Masimo Corporation is Obtaining a Fair Price for Its Shareholders (businesswire.com, 2026-02-17) — Read more
- Nasdaq Futures Down Triple Digits as Tech Stocks Slide (schaeffersresearch.com, 2026-02-17) — Read more
Full news analysis based on 30 recent articles
Generated by Everhint Lens - Quantitative Stock Analysis
Last updated: 2026-02-17 09:27:14 AM PST
Disclaimer: This is not investment advice. Always do your own research before making investment decisions.